Madame Mandy BRECQUEVILLE / PhD

Contact details

mandy.brecqueville@gmail.com
brecquevillem@ipc.unicancer.fr

Jobs

Research : NON

Techniques

- extraction ADN/ARN/protéines - séquençage - CGH - transcriptome - western blot -culture cellulaire

PhD

Title : Biologie-Santé - Spécialité Oncologie

First registration date : 1 October 2010 / 3A

Doctoral school : Sciences de la Vie et de la Santé

Thesis defense date : 27 September 2013

Subject : Caractérisation moléculaire des syndromes myéloprolifératifs non leucémie myéloide chronique

Thesis supervisor : BIRNBAUM Daniel

Thesis co-supervisor : MURATI Anne

Research unit : CRCM - Centre de Recherche en Cancérologie de Marseille

Team : Oncologie moléculaire

Master's degree

Title : pathologie humaine

June 2010 - La Timone

Publications

  • Mutations of ASXL1 gene in myeloproliferative neoplasms.
    Leukemia, 2009
    Carbuccia N., Murati A, Trouplin V, Brecqueville M, Adélaïde J, Rey J, Vainchenker W, Bernard O, Chaffanet M, Vey N, Birnbaum D & Mozziconacci MJ.
    http://www.nature.com/leu/journal/v23/n11/full/leu2009141a.html
  • Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes.
    Blood Cancer Journal, 2011
    Brecqueville M, Cervera N, Gelsi-Boyer V, Murati A, Adélaïde J, Chaffanet M, Rey J, Vey N, Mozziconacci MJ & Birnbaum D.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255259/
  • Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms.
    Blood Cancer Journal, 2011
    Brecqueville M, Cervera N, Adélaïde J, Rey J, Carbuccia N, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D, Gelsi-Boyer V & Murati A.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255245/
  • Alterations of polycomb gene BMI1 in human myeloproliferative neoplasms.
    Cell Cycle, 2012
    Brecqueville M, Adélaïde J, Bertucci F, Finetti P, Chaffanet M, & Murati A.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442924/
  • Mutation Analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in Myeloproliferative Neoplasms.
    Genes, Chromosomes & Cancer, 2012
    Brecqueville M, Rey J, Bertucci F, Coppin E, Finetti P, Carbuccia N, Cervera N, Gelsi-Boyer V, Arnoulet C, Gisserot O, Verrot D, Slama B, Vey N, Mozziconacci, MJ, Birnbaum D & Murati A.
    http://www.ncbi.nlm.nih.gov/pubmed/22489043
  • Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.
    Haematologica, 2013
    Brecqueville M, Rey J, Devillier R, Guille A, Gillet R, Adélaide J, Gelsi-Boyer V, Arnoulet C, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D & Murati A.

  • Myeloid malignancies: mutations, models and management.
    BMC Cancer, 2012
    Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V & Birnbaum D.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418560/
  • Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
    Journal of hematology & oncology, 2012
    Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ & Birnbaum D
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355025/
  • Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
    Haematologica, 2013
    Gelsi-Boyer V, Cervera N, Bertucci F, Brecqueville M, Finetti P, Murati A, Arnoulet C, Mozziconacci MJ , Mills K, Vey N & Birnbaum D.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685272/
  • Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
    American Journal of Hematology, 2012
    Devillier R, Gelsi-Boyer V, Brecqueville M, Carbuccia N, Murati A, Vey N, Birnbaum D & Mozziconacci MJ.
    http://www.ncbi.nlm.nih.gov/pubmed/22535592

Languages

Anglais : C1 - Avancé

Italien : B1 - Intermédiaire